Suppr超能文献

内镜下切除大肠大肿瘤的疗效:澳大利亚经验。

Outcomes of endoscopic resection of large colorectal neoplasms: an Australian experience.

机构信息

Sir Charles Gairdner Hospital, Department of Gastroenterology and Hepatology, Perth, Australia.

出版信息

J Gastroenterol Hepatol. 2010 Jan;25(1):84-9. doi: 10.1111/j.1440-1746.2009.05987.x. Epub 2009 Sep 27.

Abstract

BACKGROUND AND AIMS

Endoscopic resection of large colorectal neoplasms is increasingly being used as an alternative to surgery. However data on failure rates, safety and long-term outcomes remain limited. The aim of the study was to report short- and long-term outcomes from endoscopic resection of large colorectal neoplasms from a single centre and use a model to predict mortality had surgery been performed.

METHODS

Consecutive patients referred for endoscopic resection of large (> or = 20 mm) colorectal neoplasms from January 2001 to February 2008 were included. Resection details were recorded in a prospectively maintained database. Data was collected on 30-day complication rates, and follow-up colonoscopy findings. The Colorectal-POSSUM score was used to estimate mortality from open surgery.

RESULTS

There were 154 large neoplasms in 140 patients. Mean age was 68 years (range 22-94). Mean neoplasm size was 26 mm (range 20-80 mm, 24 > or = 40 mm). Complete endoscopic removal was achieved in 95% of cases. Twenty patients were referred for surgery (14%). In the endoscopy group, there were no deaths within 30 days. Twelve patients had a complication including two perforations. Endoscopic follow-up data was available in 90% of cases and five patients (4%) were found to have residual adenoma that was treated endoscopically with subsequent clearance. If surgery had been performed, the mean predicted mortality was 2.2% (range 0.5-10%). There were two deaths (10%) in patients who underwent elective surgery within 30 days.

CONCLUSION

Endoscopic resection of large colorectal neoplasms is safe and effective even for very large benign neoplasms. When the lesion is endoscopically resectable this should be the preferred treatment.

摘要

背景与目的

内镜下切除大肠较大肿瘤(>20mm)的应用越来越广泛,可作为手术的替代疗法。但目前失败率、安全性和长期疗效的数据仍然有限。本研究的目的是报告单中心内镜下切除大肠较大肿瘤的近期和远期疗效,并建立预测模型,计算如果行外科手术的话,死亡率会是多少。

方法

连续纳入 2001 年 1 月至 2008 年 2 月因大肠较大肿瘤(>20mm)而行内镜下切除术的患者。前瞻性维护数据库中记录了切除的详细信息。记录了 30 天并发症发生率和随访结肠镜检查结果。采用 Colorectal-POSSUM 评分预测外科手术死亡率。

结果

共有 140 例患者的 154 个较大肿瘤纳入本研究。患者平均年龄 68 岁(22-94 岁)。肿瘤平均大小为 26mm(20-80mm,24≥40mm)。95%的病例实现了完全内镜下切除。20 例(14%)患者被转外科手术治疗。内镜组 30 天内无死亡病例。12 例患者出现并发症,包括 2 例穿孔。90%的病例获得了内镜随访资料,5 例(4%)患者发现有残留腺瘤,采用内镜治疗,随后肿瘤完全消退。如果行外科手术治疗,预测死亡率平均为 2.2%(0.5-10%)。30 天内行择期手术的患者中有 2 例(10%)死亡。

结论

内镜下切除大肠较大肿瘤是安全有效的,即使是非常大的良性肿瘤也可切除。如果肿瘤可在内镜下切除,应作为首选治疗方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验